Your browser doesn't support javascript.
CXCL16 associates with adverse outcome and cardiac involvement in hospitalized patients with Covid-19.
Gregersen, Ida; Ueland, Thor; Holter, Jan Cato; Olsen, Maria Belland; Michelsen, Annika E; Murphy, Sarah L; Tveita, Anders Aune; Henriksen, Katerina Nezvalova; Hoel, Hedda; Nordberg, Lena Bugge; Holten, Aleksander Rygh; Edvardsen, Thor; Yang, Kuan; Heggelund, Lars; Trøseid, Marius; Müller, Fredrik; Kildal, Anders Benjamin; Dyrhol-Riise, Anne Ma; Barratt-Due, Andreas; Dahl, Tuva B; Aukrust, Pål; Halvorsen, Bente.
  • Gregersen I; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo 0027, Norway. Electronic address: ida.gregersen@medisin.uio.no.
  • Ueland T; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo 0027, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo 0318, Norway; Thrombosis Research and Expertise Center, University of Tromsø, Tromsø, Norway.
  • Holter JC; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo 0318, Norway; Department of Microbiology, Oslo University Hospital, Oslo 0424, Norway.
  • Olsen MB; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo 0027, Norway.
  • Michelsen AE; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo 0027, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo 0318, Norway.
  • Murphy SL; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo 0027, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo 0318, Norway.
  • Tveita AA; Department of Internal Medicine, Bærum Hospital, Vestre Viken Hospital Trust, Gjettum 1346, Norway; Division of Laboratory Medicine, Department of Immunology, Oslo University Hospital, Oslo 0424, Norway.
  • Henriksen KN; Department of Hematology, Oslo University Hospital, Oslo, Norway; Hospital Pharmacies, South-Eastern Norway Enterprise, Oslo, Norway.
  • Hoel H; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo 0027, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo 0318, Norway; Medical Department, Lovisenberg Diaconal Hospital, Oslo, Norway.
  • Nordberg LB; Medical Department, Diakonhjemmet Hospital, Oslo, Norway.
  • Holten AR; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo 0318, Norway; Department of Acute Medicine, Oslo University Hospital, Oslo, Norway.
  • Edvardsen T; Department of Cardiology, Oslo University Hospital, Rikshospitalet, University of Oslo, Oslo, Norway.
  • Yang K; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo 0027, Norway.
  • Heggelund L; Department of Internal Medicine, Drammen Hospital, Vestre Viken Hospital Trust, Drammen 3004, Norway; Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen 5009, Norway.
  • Trøseid M; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo 0027, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo 0318, Norway; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, Norway.
  • Müller F; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo 0318, Norway; Department of Microbiology, Oslo University Hospital, Oslo 0424, Norway.
  • Kildal AB; Department of Anesthesiology and Intensive Care, University Hospital of North Norway, Tromsø, Norway.
  • Dyrhol-Riise AM; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo 0318, Norway; Department of Infectious Diseases, Oslo University Hospital, Ullevål, Oslo, Norway.
  • Barratt-Due A; Division of Laboratory Medicine, Department of Immunology, Oslo University Hospital, Oslo 0424, Norway; Department of Anaesthesia and Intensive Care Medicine, Oslo University Hospital, Oslo, Norway.
  • Dahl TB; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo 0027, Norway; Department of Acute Medicine, Oslo University Hospital, Oslo, Norway.
  • Aukrust P; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo 0027, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo 0318, Norway; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, Norway.
  • Halvorsen B; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo 0027, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo 0318, Norway.
J Infect ; 85(6): 702-769, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-2061548
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: J Infect Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: J Infect Year: 2022 Document Type: Article